Supplemental material
Open access
4,070
Views
2
CrossRef citations to date
0
Altmetric
Report
Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering
Yuji Horia Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanCorrespondence[email protected]
View further author information
, View further author information
Ken Ohminea Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Hitoshi Katadab Chugai Pharmabody Research Pte. Ltd, SingaporeView further author information
, Yuki Noguchia Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Kazuki Satoa Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Takeru Nambub Chugai Pharmabody Research Pte. Ltd, SingaporeView further author information
, Lam Runyi Adelineb Chugai Pharmabody Research Pte. Ltd, SingaporeView further author information
, Gan Siok Wanb Chugai Pharmabody Research Pte. Ltd, Singapore
https://orcid.org/0000-0002-6982-4492View further author information
Kenta Harayaa Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Kazuhisa Ozekia Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Masahiko Nanamia Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Tatsuhiko Tachibanaa Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Zenjiro Sampeia Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, JapanView further author information
, Taichi Kuramochia Research Division, Chugai Pharmaceutical Co, Ltd, Gotemba, Japan
https://orcid.org/0000-0001-7242-7124View further author information
Junichi Nezuc Research Division, Chugai Pharmaceutical Co, Ltd, Chuo-ku, Tokyo, JapanView further author information
, Kunihiro Hattorid Research Division, Chugai Pharmaceutical Co, Ltd, Kamakura, JapanView further author information
& Tomoyuki Igawac Research Division, Chugai Pharmaceutical Co, Ltd, Chuo-ku, Tokyo, JapanView further author information
show all
Article: 2068213
|
Received 07 Dec 2021, Accepted 17 Apr 2022, Published online: 28 Apr 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.